Skip to content

Reprogramming of lipid metabolism by PFKL promotes the adaptation of pancreatic ductal adenocarcinoma to glucose deprivation.

Aug 2026 · Cellular Signalling · Vol 148, pp. 112839 · 0 citations · 39 references
Medicine

TL;DR

PFKL plays a key role in coordinating LD-mitochondria tethering under glucose deprivation in PDAC, and targeting the p38-PFKL-PLIN2-CPT1A axis may represent a promising therapeutic strategy.

Abstract

BACKGROUND/

Objective

Lipid droplet (LD)-mitochondria tethering is essential for fatty acid oxidation (FAO), which sustains tumor cell survival under nutrient-deprivation conditions. However, how LD-mitochondria contact is regulated in pancreatic ductal adenocarcinoma (PDAC) is unclear.

Methods

This study investigated the signaling pathway that regulates lipid droplet-mitochondria interaction in PDAC under conditions of glucose deprivation, utilizing molecular interaction assays, cellular functional experiments, and clinical sample validation.

Results

Glucose deprivation activated p38, leading to phosphorylation of phosphofructokinase, liver type (PFKL) at T331, which in turn phosphorylated the LD protein perilipin 2 (PLIN2) at S159 in PDAC cells. This enhanced the binding of PLIN2 to mitochondrial protein carnitine palmitoyltransferase-1 A (CPT1A), thereby promoting LD-mitochondria tethering. Disruption of this axis impaired LD-mitochondria contact, reduced lipid consumption and ATP production, decreased cell viability, increased apoptosis, and suppressed tumor growth. In human PDAC samples, phosphorylation levels at both PFKL T331 and PLIN2 S159 were elevated and showed a positive correlation.

Conclusion

PFKL plays a key role in coordinating LD-mitochondria tethering under glucose deprivation in PDAC, and targeting the p38-PFKL-PLIN2-CPT1A axis may represent a promising therapeutic strategy.

View source

Similar papers

Open access Sep 2026

KDM4B Maintains Pyruvate Dehydrogenase Complex Expression to Support Mitochondrial Metabolism and Survival in Cancer Cells

Background/Objectives: Metabolic reprogramming is a hallmark of cancer and requires coordinated regulation of glycolysis and mitochondrial metabolism. The pyruvate dehydrogenase complex (PDC) links these pathways by catalyzing the conversion of pyruvate to acetyl-CoA, yet the epigenetic mechanisms regulating PDC expres...

Sachiko Sato, A. Hasan, Mami Obara et al. · 0 citations
Review Open access Sep 2026

Metabolic Reprogramming Of Macrophages In Breast Cancer: Mechanisms And Therapeutic Implications.

In summary, in-depth elucidation of the molecular mechanisms underlying macrophage metabolic reprogramming and their metabolic crosstalk with breast cancer cells will provide new insights and novel therapeutic targets for the precise immunometabolic therapy of breast cancer.

Jiao-Yu Zhang, Ru-Yu-Wang-Hsin-Ti Yang · 0 citations
Open access Sep 2026

IRE1α-XBP1s signaling links lipid homeostasis to hypoxic maladaptation and KRAS inhibitor responses in pancreatic ductal adenocarcinoma.

Pancreatic ductal adenocarcinoma (PDAC) is among the most hypoxic human tumors. Because fatty acid (FA) desaturation is oxygen-dependent, hypoxia can limit monounsaturated FA (MUFA) production, increase membrane lipid saturation, and activate endoplasmic reticulum stress responses, including IRE1α-XBP1s. Here, we found...

Yan-Qing Jiang, Cassidy Pagen, Gusangyu Yin et al. · 0 citations
Open access Sep 2026

Glucose-induced histone lactylation confers metformin resistance in colorectal cancer stem cells

Cancer stem cells (CSCs) can adapt their metabolism, which limits the effectiveness of therapies targeting metabolic pathways. Here we show that high glucose conditions promote metformin resistance in CD133⁺ colorectal CSCs by driving a switch from glucose dependence to lipid use. Mechanistically, metformin increases...

Xiangrui Li, Li Deng, Tian-Ge Zhang et al. · 0 citations
Open access Sep 2026

ALDH1B1 promotes mitochondrial γ-butyrobetaine biosynthesis and fatty acid oxidation in colorectal cancer

Metabolic reprogramming is a hallmark of cancer cells, and stem-like populations often upregulate aldehyde dehydrogenases (ALDHs). Functional studies have established essential roles for individual ALDH isoforms in tumor initiation, progression, and metastasis; however, the mechanisms by which these enzymes promote mal...

Zhi-Ping Feng, Thomas E. Bearrood, Sydney L. Campbell et al. · 0 citations
Review Open access Aug 2026

Metabolic reprogramming in pancreatic cancer: interplay of glucose, lipid, and amino acid metabolism in tumor progression

This article systematically reviews the molecular mechanisms underlying the dysregulation of three major nutrient metabolic pathways—glucose, lipid, and amino acid metabolism—and their interconnected regulatory networks and suggests a novel approach to improving the prognosis of pancreatic cancer.

Ze-Liang Zhang, Ying Tian, Bo Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.